AD is pathologically defined by the presence of extracellular amyloid-β (Aβ) deposits and intracellular aggregates of tau protein [1], but recent studies have demonstrated that a large number of AD cases exhibit a multitude of co-existing pathologies including aggregates of α-synuclein and TDP-43 [11–13]. This evidence concerns the gene MAPT and Alzheimer disease.